PFM Health Sciences’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,162,411
| Closed | -$18M | – | 82 |
|
|
2023
Q1 | $18M | Hold |
2,162,411
| – | – | 0.8% | 44 |
|
|
2022
Q4 | $24.8M | Hold |
2,162,411
| – | – | 0.89% | 39 |
|
|
2022
Q3 | $27.2M | Hold |
2,162,411
| – | – | 0.99% | 44 |
|
|
2022
Q2 | $22.9M | Buy |
+2,162,411
| New | +$22.9M | 0.87% | 43 |
|
|
2021
Q3 | – | Sell |
-708,927
| Closed | -$11.2M | – | 79 |
|
|
2021
Q2 | $11.2M | Buy |
+708,927
| New | +$11.2M | 0.35% | 57 |
|